Suppr超能文献

帕瑞昔布在改善全膝关节或全髋关节置换术后疼痛方面的疗效:系统评价和荟萃分析。

The efficacy of parecoxib in improving pain after total knee or total hip arthroplasty: Systematic review and meta-analysis.

机构信息

Department of Orthopedics, Ninghai First Hospital, Ningbo, Zhejiang, China.

Department of Pharmacy, The Third Hospital of Quzhou, Zhejiang, China.

出版信息

Medicine (Baltimore). 2022 Sep 23;101(38):e30748. doi: 10.1097/MD.0000000000030748.

Abstract

BACKGROUND

The cyclooxygenase-2 (COX-2) selective inhibitor parecoxib is widely used in the treatment of pain and inflammation. Parecoxib has been adopted for use for postoperative analgesia following a range of surgical procedures (orthopedic, general, gynecological, and dental surgery). Total knee or total hip arthroplasty (THA) surgery is mostly done in older patients, so postoperative analgesics need to be used more carefully, and the safety and efficacy of parecoxib in this type of surgery need to be further verified. The aim of this study was to investigate the effects of parecoxib on patient safety, cumulative morphine consumption and was at 24 and 48 hours in the analgesic treatment of total knee or THA for meta-analysis and systematic review, with few studies in this area so far.

METHODS

We searched the Online Database Cochrane Library, PubMed, Web of Science, EMBASE, and CBM (SinoMed), CNKI, VIP, WANFANG up to January 2021. According to the value of I2, the random-effect model or fixed-effect model was supposed to combine data from studies, respectively. Publication bias was assessed through funneling plot and Beggs test. Review Manager 5.3 and Stata 16.0 software were applied to perform the statistical analyses.

RESULTS

Eleven RCTs which involved 1690 participants were included in this study. The meta-analysis indicated parecoxib sodium could not significantly reduce the incidence of adverse events after total knee or THA compared with placebo. There was no statistical significance in incidence of nausea and vomiting. 24 hours resting VAS score was statistically significant between the group. The 48-hour resting VAS scores did not indicate a significant difference between the groups.

CONCLUSION

Parecoxib can reduce the incidence of adverse events after total knee or total hip surgery to some extent but cannot reduce the incidence of nausea and vomiting. Twenty-four hour postoperative analgesia is better than placebo, but 48 hours after operation analgesia is the same as placebo.

摘要

背景

环氧化酶-2(COX-2)选择性抑制剂帕瑞昔布广泛用于治疗疼痛和炎症。帕瑞昔布已被用于多种手术(骨科、普通外科、妇科和牙科手术)的术后镇痛。全膝关节或全髋关节置换术(THA)手术大多在老年患者中进行,因此需要更小心地使用术后镇痛药,并且需要进一步验证帕瑞昔布在这种类型手术中的安全性和有效性。本研究旨在调查帕瑞昔布对全膝关节或 THA 术后镇痛治疗中患者安全性、累积吗啡消耗量和 24 小时和 48 小时的影响,到目前为止,该领域的研究较少。

方法

我们检索了 Cochrane 图书馆在线数据库、PubMed、Web of Science、EMBASE 和 CBM(中国生物医学文献数据库)、CNKI、VIP、WANFANG,检索时间截至 2021 年 1 月。根据 I2 值,分别采用随机效应模型或固定效应模型对研究数据进行合并。通过漏斗图和 Beggs 检验评估发表偏倚。采用 Review Manager 5.3 和 Stata 16.0 软件进行统计分析。

结果

本研究纳入了 11 项 RCT,共 1690 名参与者。荟萃分析表明,与安慰剂相比,帕瑞昔布钠不能显著降低全膝关节或 THA 后不良事件的发生率。恶心和呕吐的发生率没有统计学意义。两组 24 小时静息 VAS 评分有统计学意义。两组 48 小时静息 VAS 评分无统计学差异。

结论

帕瑞昔布在一定程度上可以降低全膝关节或全髋关节置换术后不良事件的发生率,但不能降低恶心和呕吐的发生率。术后 24 小时镇痛效果优于安慰剂,但术后 48 小时镇痛效果与安慰剂相同。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fd6a/9509050/a4856213cc9c/medi-101-e30748-g001.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验